John Restaino, Jr.

Dr. John M. Restaino, Jr. joins Milberg as a Senior Partner working out of the Denver, Colorado area. A non-practicing podiatric surgeon and an attorney with over 30 years of experience, Dr. Restaino focuses on Mass Tort and Medical Malpractice cases.

Dr. Restaino practiced podiatric surgery from 1980 until 1990 after graduating from California College of Podiatric Medicine and magna cum laude from Farleigh Dickinson University. In 1991, he began the practice of law after receiving his J.D. from Western State College of Law. Relying on his unique experience and perspective, Dr. Restaino enjoys looking “outside the box” in the development of specific aspects of litigation, including the science pertaining to each litigation, the development of expert witnesses, and the cross-examination of defense expert witnesses.

Dr. Restaino received his Master of Public Health degree from the Division of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. An Adjunct Associate Professor at the University of South Carolina College of Pharmacy, he actively conducts pharmacovigilance and pharmacoepidemiology. He frequently lectures at legal seminars and has been invited to lecture at the University of South Carolina, Johns Hopkins, Northwestern College of Medicine, and Harvard.

Outside the office, Dr. Restaino enjoys martial arts and holds a Black Belt in Kenpo karate and a 2nd degree Black Belt in Okinawan karate. He is a two-time winner in the Kenpo Internationals Black Belt Heavyweight division/senior division. He also enjoys SCUBA diving and holds an “Instructor” rating from the North American Association of Underwater Instructors (NAUI). He is both Dive Master and Rescue Diver qualified, having previously taught Dive Medicine at the NAUI College in Laguna Niguel, California.

Notable Cases

• One of the initial attorneys to develop the Silicone Breast Implant litigation
• Plaintiff Steering Committee, Diet Pill Litigation MDL
• Chair, Science Committee, Propulsid MDL
• Developed that aspect of litigation linking the use of Propulsid and Sudden Infant Death Syndrome
• Chair, Science Committee, Rezulin MDL
• Science Committee, Ortho Evra MDL
• Co-Chair, Science Committee, Phenylpropanolamine MDL
• Co-Chair, Vioxx MDL
• Science Committee, Zyprexa MDL
• Science Committee, Yaz/Yasmin Oral Contraceptive MDL
• Science Committee, Gadolinium
• Co-Chair, Science Committee, DePuy Hip MDL
• Science Committee, Pradaxa MDL
• Co-Chair, Trans Vaginal Mesh MDL
• Plaintiff Executive Committee, Plaintiff Steering Committee, and Chair of the Science Committee, Incretin Mimetics MDL
• Plaintiff Steering Committee and Science Committee, Lipitor MDL
• Science Committee, Talc MDL
• Science Committee, Zantac MDL
• Developed the Proton Pump Inhibitor/Gastric Cancer litigation
• Developed the fluroquinolone/aortic aneurysm & dissection litigation

Practice Areas

• Personal Injury
• Medical Malpractice
• Wrongful Death

Education

• M.P.H., Johns Hopkins Bloomberg School of Public Health, 2006
• J.D., Western State College of Law, 1986
• D.P.M., California College of Podiatric Medicine, 1974
• B.S., Fairleigh Dickinson University, magna cum laude, 1974

Bar Admissions

California, 1986

Awards

Best Lawyers in America, 2006-2025

Professional Activities

• University of South Carolina College of Pharmacy, Adjunct Associate Professor
• Southern Network of Adverse Event Reporting (SONAR), pharmacovigilance and pharmacoepidemiology